收藏切换
Research progress on strategies to target intestinal microbiota to improve drug resistance in tumor immunotherapy
收藏切换
PDF
Hui-ling LI1, Bi-qing LIU2, Ying-nan FENG1, Xin HU1, 3, Lan ZHANG1, Xian-zhe DONG1, *
Acta Pharmaceutica Sinica | 2025, 60(2) : 260 - 268
Less
收藏切换
Acta Pharmaceutica Sinica | 2025, 60(2): 260-268
Reviews
Research progress on strategies to target intestinal microbiota to improve drug resistance in tumor immunotherapy
Full
Hui-ling LI1, Bi-qing LIU2, Ying-nan FENG1, Xin HU1, 3, Lan ZHANG1, Xian-zhe DONG1, *
Affiliations
  • 1. Department of Pharmacy, Xuanwu Hosptial, Capital Medical University, Beijing 100053, China
  • 2. Department of Pharmacy, Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing 100020, China
  • 3. College of Pharmacy, Zunyi Medical University, Zunyi 563000, China
Published: 2025-02-12 doi: 10.16438/j.0513-4870.2024-0740
Outline
收藏切换

A growing body of research points out that gut microbiota plays a key role in tumor immunotherapy. By optimizing the composition of intestinal microbiota, it is possible to effectively improve immunotherapy resistance and enhance its therapeutic effect. This article comprehensively analyzes the mechanism of intestinal microbiota influencing tumor immunotherapy resistance, expounds the current strategies for targeted regulation of intestinal microbiota, such as traditional Chinese medicine and plant components, fecal microbiota transplantation, probiotics, prebiotics and dietary therapy, and explores the potential mechanisms of these strategies to improve patients' resistance to tumor immunotherapy. At the same time, the article also briefly discusses the prospects and challenges of targeting intestinal microbiota to improve tumor immunotherapy resistance, which provides a reference for related research to help the strategy research of reversing tumor immunotherapy resistance.

intestinal microbiota  /  tumor immunotherapy  /  targeted regulation  /  improve drug resistance mechanism  /  application challenge
Hui-ling LI, Bi-qing LIU, Ying-nan FENG, Xin HU, Lan ZHANG, Xian-zhe DONG. Research progress on strategies to target intestinal microbiota to improve drug resistance in tumor immunotherapy[J]. Acta Pharmaceutica Sinica, 2025 , 60 (2) : 260 -268 . DOI: 10.16438/j.0513-4870.2024-0740
Year 2025 volume 60 Issue 2
PDF
252
114
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2024-0740
  • Receive Date:2024-07-31
  • Online Date:2025-11-07
  • Published:2025-02-12
Article Data
Affiliations
History
  • Received:2024-07-31
  • Revised:2024-10-23
Funding
Affiliations
    1. Department of Pharmacy, Xuanwu Hosptial, Capital Medical University, Beijing 100053, China
    2. Department of Pharmacy, Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing 100020, China
    3. College of Pharmacy, Zunyi Medical University, Zunyi 563000, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2024-0740
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT